comparemela.com

Latest Breaking News On - Prnewswire biolase inc - Page 3 : comparemela.com

BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year.

John beaverMichael polyviou todd kehrliPrnewswire biolase incCompany adjustedSource biolase incWaterlase exclusive trial programBiolase incExchange commissionYear financialWaterlase exclusive trialChief executiveFull year financial guidanceWaterlase expressPrivate litigation reform actOperating activitiesInvesting activities

BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE

BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John beaverPrnewswire biolase incBiolase incSource biolase incGroup llcmichael polyviou todd kehrliChief executive officerJennifer brightChief financial officerWaterlase expressTodd kehrli

BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Third Annual.

John beaverMichael polyviou todd kehrliPrnewswire biolase incBiolase incSource biolase incChief executive officerJennifer brightChief financial officerWaterlase express

BIOLASE REJECTS SONENDO S PATENTLY ABSURD CLAIMS

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the world s leading dental laser company, today released the following statement in response to the attempt by.

John beaverBjarne bergheimPrnewswire biolase incBiolase incSonendo incChief executive officerWaterlase expressPrivate litigation reform act

BIOLASE to Participate in the Benchmark Discovery One-on-One Investor Conference on December 1, 2022 in New York

/PRNewswire/ BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11th Annual.

New yorkUnited statesJohn beaverMichael polyviou todd kehrliPrnewswire biolase incBiolase incGroup incSource biolase incChief executive officeChief financial officerJennifer bright

vimarsana © 2020. All Rights Reserved.